176 related articles for article (PubMed ID: 32017077)
1. Follistatin-like 1: A dual regulator that promotes cardiomyocyte proliferation and fibrosis.
Hu S; Liu H; Hu Z; Li L; Yang Y
J Cell Physiol; 2020 Sep; 235(9):5893-5902. PubMed ID: 32017077
[TBL] [Abstract][Full Text] [Related]
2. FSTL1 as a Potential Mediator of Exercise-Induced Cardioprotection in Post-Myocardial Infarction Rats.
Xi Y; Gong DW; Tian Z
Sci Rep; 2016 Aug; 6():32424. PubMed ID: 27561749
[TBL] [Abstract][Full Text] [Related]
3. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.
Shen H; Cui G; Li Y; Ye W; Sun Y; Zhang Z; Li J; Xu G; Zeng X; Zhang Y; Zhang W; Huang Z; Chen W; Shen Z
Stem Cell Res Ther; 2019 Jan; 10(1):17. PubMed ID: 30635025
[TBL] [Abstract][Full Text] [Related]
4. Identification of follistatin-like 1 by expression cloning as an activator of the growth differentiation factor 15 gene and a prognostic biomarker in acute coronary syndrome.
Widera C; Giannitsis E; Kempf T; Korf-Klingebiel M; Fiedler B; Sharma S; Katus HA; Asaumi Y; Shimano M; Walsh K; Wollert KC
Clin Chem; 2012 Aug; 58(8):1233-41. PubMed ID: 22675198
[TBL] [Abstract][Full Text] [Related]
5. Epicardial FSTL1 reconstitution regenerates the adult mammalian heart.
Wei K; Serpooshan V; Hurtado C; Diez-Cuñado M; Zhao M; Maruyama S; Zhu W; Fajardo G; Noseda M; Nakamura K; Tian X; Liu Q; Wang A; Matsuura Y; Bushway P; Cai W; Savchenko A; Mahmoudi M; Schneider MD; van den Hoff MJ; Butte MJ; Yang PC; Walsh K; Zhou B; Bernstein D; Mercola M; Ruiz-Lozano P
Nature; 2015 Sep; 525(7570):479-85. PubMed ID: 26375005
[TBL] [Abstract][Full Text] [Related]
6. Dynamic resistance exercise increases skeletal muscle-derived FSTL1 inducing cardiac angiogenesis via DIP2A-Smad2/3 in rats following myocardial infarction.
Xi Y; Hao M; Liang Q; Li Y; Gong DW; Tian Z
J Sport Health Sci; 2021 Sep; 10(5):594-603. PubMed ID: 33246164
[TBL] [Abstract][Full Text] [Related]
7. Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture.
Maruyama S; Nakamura K; Papanicolaou KN; Sano S; Shimizu I; Asaumi Y; van den Hoff MJ; Ouchi N; Recchia FA; Walsh K
EMBO Mol Med; 2016 Aug; 8(8):949-66. PubMed ID: 27234440
[TBL] [Abstract][Full Text] [Related]
8. MiR-29a in mesenchymal stem cells inhibits FSTL1 secretion and promotes cardiac myocyte apoptosis in hypoxia-reoxygenation injury.
Li KS; Jiang WP; Li QC; Zhang HW; Bai Y; Zhang X; Li HY
Cardiovasc Pathol; 2020; 46():107180. PubMed ID: 31945680
[TBL] [Abstract][Full Text] [Related]
9. Follistatin-like protein 1 regulates chondrocyte proliferation and chondrogenic differentiation of mesenchymal stem cells.
Chaly Y; Blair HC; Smith SM; Bushnell DS; Marinov AD; Campfield BT; Hirsch R
Ann Rheum Dis; 2015 Jul; 74(7):1467-73. PubMed ID: 24641944
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.
Shang H; Liu X; Guo H
Mol Med Rep; 2017 Nov; 16(5):7119-7123. PubMed ID: 28901425
[TBL] [Abstract][Full Text] [Related]
11. Angiocrine FSTL1 (Follistatin-Like Protein 1) Insufficiency Leads to Atrial and Venous Wall Fibrosis via SMAD3 Activation.
Jiang H; Zhang L; Liu X; Sun W; Kato K; Chen C; Li X; Li T; Sun Z; Han W; Zhang F; Xiao Q; Yang Z; Hu J; Qin Z; Adams RH; Gao X; He Y
Arterioscler Thromb Vasc Biol; 2020 Apr; 40(4):958-972. PubMed ID: 32078339
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1 induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts.
Zheng X; Qi C; Zhang S; Fang Y; Ning W
Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L240-L251. PubMed ID: 28495857
[TBL] [Abstract][Full Text] [Related]
13. Mitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk1/2 in human lung cancer cells.
Bae K; Park KE; Han J; Kim J; Kim K; Yoon KA
Oncotarget; 2016 Apr; 7(14):18076-84. PubMed ID: 26716515
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic inactivation of follistatin-like 1 mediates tumor immune evasion in nasopharyngeal carcinoma.
Zhou X; Xiao X; Huang T; Du C; Wang S; Mo Y; Ma N; Murata M; Li B; Wen W; Huang G; Zeng X; Zhang Z
Oncotarget; 2016 Mar; 7(13):16433-44. PubMed ID: 26918942
[TBL] [Abstract][Full Text] [Related]
15. Follistatin-like 1 and its paralogs in heart development and cardiovascular disease.
Horak M; Fairweather D; Kokkonen P; Bednar D; Bienertova-Vasku J
Heart Fail Rev; 2022 Nov; 27(6):2251-2265. PubMed ID: 35867287
[TBL] [Abstract][Full Text] [Related]
16. Follistatin-like 1 is a myokine regulating lipid mobilization during endurance exercise and recovery.
Nam JS; Park SJ; Ahn CW; Cho ES; Kim HJ; Kim Y
Obesity (Silver Spring); 2024 Feb; 32(2):352-362. PubMed ID: 38018497
[TBL] [Abstract][Full Text] [Related]
17. Follistatin-like 1 is an Akt-regulated cardioprotective factor that is secreted by the heart.
Oshima Y; Ouchi N; Sato K; Izumiya Y; Pimentel DR; Walsh K
Circulation; 2008 Jun; 117(24):3099-108. PubMed ID: 18519848
[TBL] [Abstract][Full Text] [Related]
18. Persistent Myocardial Production of Follistatin-like 1 Is Associated With Left Ventricular Adverse Remodeling in Patients With Myocardial Infarction: Myocardial production of FSTL1 in AMI patients.
Uematsu M; Nakamura K; Nakamura T; Watanabe Y; Yoshizaki T; Deyama J; Kobayashi T; Fujioka D; Saito Y; Kawabata K; Obata JE; Kugiyama K
J Card Fail; 2020 Aug; 26(8):733-738. PubMed ID: 32470377
[TBL] [Abstract][Full Text] [Related]
19. Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.
Liu Y; Tan X; Liu W; Chen X; Hou X; Shen D; Ding Y; Yin J; Wang L; Zhang H; Yu Y; Hou J; Thompson TC; Cao G
Chin J Cancer; 2018 Jan; 37(1):2. PubMed ID: 29357946
[TBL] [Abstract][Full Text] [Related]
20. Follistatin-like I promotes endometriosis by increasing proinflammatory factors and promoting angiogenesis.
Lei ST; Li MQ; Cao YL; Hou SH; Peng HY; Zhao D; Sun J
Reproduction; 2021 Dec; 163(1):57-68. PubMed ID: 34866594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
